NASDAQ:CLSN
Delisted

Celsion Stock News

etoro logo Buy CLSN
*Your capital is at risk
$1.56
+0.0600 (+4.00%)
At Close: Jan 27, 2023

Celsion Co. (NASDAQ:CLSN) Sees Significant Decrease in Short Interest

05:18pm, Saturday, 04'th Dec 2021 Dakota Financial News
Celsion Co. (NASDAQ:CLSN) was the target of a significant drop in short interest in November. As of November 15th, there was short interest totalling 1,720,000 shares, a drop of 27.1% from the October 31st total of 2,360,000 shares. Based on an average trading volume of 961,300 shares, the short-interest ratio is currently 1.8 days. A []
Celsion Corporation’s GEN-1 IL-12 Program in Advanced Ovarian Cancer to be Featured in Poster Presentation
Celsion Corporation s GEN-1 IL-12 Program in Ad vanced Ovarian Cancer to be Featured in Poster Presentation
Celsion Corporation 's GEN-1 IL-12 Program in Ad vanced Ovarian Cancer to be Featured in Poster Presentation
Sesen Bio, Inc. (SESN) with the stream of -0.92% also noticed, India Celsion Corporation (CLSN) encountered a rapid change of -5.25% in the last hour of trading session. Sesen Bio, The post Volume Sizzler: Sesen Bio, Inc. (NASDAQ:SESN), Celsion Corporation (NASDAQ:CLSN) appeared first on Stocks Equity .
Celsion Corporation (CLSN) with the stream of -5.25% also noticed, India Evolve Transition Infrastructure LP (SNMP) encountered a rapid change of -4.87% in the last hour of Fridays trading session. The post Latest Tally Of Analyst Opinions: Celsion Corporation (NASDAQ:CLSN), Evolve Transition Infrastructure LP (AMEX:SNMP) appeared first on Stocks Equity .

Celsion Co. (NASDAQ:CLSN) Expected to Post Quarterly Sales of $120,000.00

03:44am, Thursday, 25'th Nov 2021 Dakota Financial News
Equities research analysts expect Celsion Co. (NASDAQ:CLSN) to post $120,000.00 in sales for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Celsions earnings. The highest sales estimate is $130,000.00 and the lowest is $100,000.00. Celsion reported sales of $130,000.00 in the same quarter last year, which indicates a negative year over []
Outlook Therapeutics, Inc. (OTLK) with the stream of -4.22% also noticed, India Celsion Corporation (CLSN) encountered a rapid change of -2.68% in the last hour of Monday’s trading session. Outlook … The post Comparable Company Analysis: Outlook Therapeutics, Inc. (NASDAQ:OTLK), Celsion Corporation (NASDAQ:CLSN) appeared first on Stocks Equity .

Celsion Co. (NASDAQ:CLSN) Shares Bought by Vanguard Group Inc.

09:04am, Monday, 22'nd Nov 2021 Dakota Financial News
Vanguard Group Inc. raised its holdings in Celsion Co. (NASDAQ:CLSN) by 17.8% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 3,678,489 shares of the biotechnology companys stock after acquiring an additional 555,877 shares during the period. Vanguard Group Inc.s holdings in Celsion were worth $4,672,000 at []
Artelo Biosciences, Inc. (ARTL) with the stream of -3.73% also noticed, India Celsion Corporation (CLSN) encountered a rapid change of -0.54% in the last hour of Fridays trading session. Artelo The post Valuing Stock Using Ratios and Multiples: Artelo Biosciences, Inc. (NASDAQ:ARTL), Celsion Corporation (NASDAQ:CLSN) appeared first on Stocks Equity .
Celsion Corporation (CLSN) with the stream of -3.48% also noticed, India PolarityTE, Inc. (PTE) encountered a rapid change of 0.70% in the last hour of Tuesdays trading session. Celsion Corporation The post Up to Date Trending Stock: Celsion Corporation (NASDAQ:CLSN), PolarityTE, Inc. (NASDAQ:PTE) appeared first on Stocks Equity .

Celsion (NASDAQ:CLSN) Issues Earnings Results

05:38pm, Tuesday, 16'th Nov 2021 Dakota Financial News
Celsion (NASDAQ:CLSN) issued its quarterly earnings data on Monday. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts consensus estimates of ($0.08) by $0.02, MarketWatch Earnings reports. Celsion had a negative return on equity of 50.81% and a negative net margin of 4,444.40%. During the same quarter in the prior []
Celsion Corporation (CLSN) CEO Michael Tardugno on Q3 2021 Results - Earnings Call Transcript
Balance Sheet Supports Focus o n Immuno-Oncology and Next-Generation Vaccine Initiative
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE